Download our White Paper: Literature Monitoring in Pharmacovigilance Challenges and Opportunities. here
From Data to Evidence
biologit unites deep expertise in multivigilance including human, veterinary, cosmetics, nutraceuticals and medical devices, with artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep products safe for all.
-
Our mission is to develop technology to enable users enjoy, learn, and more efficiently deliver meaningful results in line with global regulatory requirements and to prevent harm.
-
Our vision is to ensure safety by simplifying the detection of risks and events from development to post-market.
-
Our values are to innovate transparently and ethically, do good with integrity, do together.
Leadership Team
Immunologist and Pharmacovigilance Professional with strong focus on innovation and extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams.
Over 25 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority, Clinical Research Organisation, and more recently Start-up.
Experienced Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed Senior Engineering/Engineering management roles on large scale Cloud Infrastructure, Fintech, Healthcare and Artificial Intelligence Services.
Scientist with 10+ years experience in consulting, strategy and general management gained by working with multiple life science offerings and teams at a global clinical research organisation.
Investors
David Shanahan
Tom Howard
Gerard Ryan
Enterprise Ireland
Ken O’Connell
Scientific Advisory Board
Lucy Hederman
Ana Volpe
Jeff Caselden
Academic and Industry Partners
